2nd Quarter - Report

PHARMAVITE LLC for PHARMAVITE LLC

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Food Industry (safety, labeling, etc.) FOO

Support for legal, regulatory pathway for hemp-derived cannabidiol (CBD)

LobbyistCovered position, as disclosed
INGRID LEBERT New —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Budget/Appropriations BUD

Increase funding for the Office of Dietary Supplement Programs within FDA

LobbyistCovered position, as disclosed
INGRID LEBERT —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Consumer Issues/Safety/Products CSP

H.R.6058-SHOP SAFE act, a bill to provide for contributory liability for certain electronic commerce platforms for use of a counterfeit mark by a third party on such platforms; all provisions relating to dietary supplements

LobbyistCovered position, as disclosed
INGRID LEBERT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 6058 (116th)

Taxation/Internal Revenue Code TAX

S. 12 - Health Savings Act, a bill to amend the Internal Revenue Code of 1986 to improve access to health care through expanded health savings accounts; all provisions relating to dietary supplements

LobbyistCovered position, as disclosed
INGRID LEBERT —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 12 (116th)

Manufacturing MAN

Support for COVID-19 relief packages; all provisions relating to dietary supplements

LobbyistCovered position, as disclosed
INGRID LEBERT —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.